Company intelligence
Menarini Stemline
About Menarini Stemline
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer. Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Netiquette & Privacy Notice: https://bit.ly/48X6JSN
Verified activity
Signals from Menarini Stemline
5 published signals
Presence & Recognition
Menarini Stemline is attending the Society of Hematologic Oncology 2026 Annual Meeting to connect with scientific leaders and share ongoing research for patients living with blood cancers.
Reported by Menarini Stemline
Presence & Recognition
Menarini Stemline announced that PharmaSOS will be back in Princeton in September.
Reported by Wing Chan
Presence & Recognition
Menarini Stemline joined the global community in recognizing Blood Cancer Awareness Month.
Reported by Menarini Stemline
Presence & Recognition
Menarini Stemline employee Amit Grover is attending Fierce Pharma Week 2026 at the Pennsylvania Convention Center from September 14 to 17, 2026.
Reported by Amit Grover
Presence & Recognition
Menarini Stemline is participating in the IMS 2026 conference in Glasgow to discuss myeloma research and care.
Reported by Bruno Schoentjes